The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,274.00
Bid: 1,268.00
Ask: 1,276.00
Change: 6.00 (0.47%)
Spread: 8.00 (0.631%)
Open: 1,298.00
High: 1,298.00
Low: 1,242.00
Prev. Close: 1,268.00
VCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM and Q1 Interim Management Statement

6 Feb 2020 07:00

RNS Number : 1261C
Victrex PLC
06 February 2020
 
 

 

 

6 February 2020

Victrex plc - AGM and Q1 Interim Management Statement

'Solid start to FY 2020 against weaker comparatives; expectations unchanged'

 

Victrex plc, an innovative world leader in high performance polymer solutions, today releases its first quarter (Q1) Interim Management Statement ahead of its Annual General Meeting (AGM) being held today. Q1 covers the period 1 October to 31 December 2019.

Against much weaker comparatives, the Group saw an initial improvement during Q1. Automotive delivered good year on year and sequential growth, partly reflecting phasing, whilst Electronics and Value Added Resellers continued to see some signs of stability. Aerospace growth continued, although we are mindful of some headwinds within the industry this year, whilst Energy was notably weaker. In Medical, we saw a stable performance, with good growth continuing in Asia.

For Q1 as a whole, revenue of £67.7m was up 6% on the prior year (Q1 2019: £64.1m), with Q1 Group sales volume of 877 tonnes being up 7% on the prior year (Q1 2019: 822 tonnes). On a year to date basis, the Group remains ahead of last year, with performance in January being broadly in line with the strong January of the prior year.

Mega-programmes

Our pipeline of 'mega-programmes' remains strong. In Aerospace, we acquired the remaining equity in the TxV Aero Composites business from Tri-Mack. Our US facility in Rhode Island continues to manufacture a range of composite products, delivering commercial and prototype revenue. In Magma, Victrex is currently supporting the qualification pipe project for TechnipFMC's new Hybrid Flexible pipe targeted at opportunities in Brazil. Several smaller projects are also expected to deliver revenue this year, including in the Gulf of Mexico, North Sea and West Africa. In our PEEK Knee programme, we are moving closer to securing a second partner, as well as progressing discussions with major OEMs in this market.

 

Joint-venture investment in China

 

As previously communicated, Victrex completed a class 2 transaction on 13th January 2020, to create a joint-venture in China which will, subject to certain performance conditions, build and operate a 1,500 tonne PEEK manufacturing plant to serve that market. Commissioning of the facility is anticipated in early 2022, with Victrex's share of the overall investment expected to total £32m.

 

Financial position

Victrex retains a highly cash generative business model, with no material change to its financial position since 30 September 2019. Currency remains a modest tailwind for FY 2020, although we note that Sterling's rerating over recent months now implies a growing headwind for FY 2021.

Outlook

Jakob Sigurdsson, Chief Executive of Victrex, said: "This is a solid start to FY 2020, although it is against weaker comparatives in the prior year.

"Whilst it is pleasing to see some year on year progress in Automotive, partly reflecting phasing, and continuing signs of stability in Electronics and Value Added Resellers, we note the weaker performance in Energy, in line with recent industry commentary. Overall, our expectations are unchanged and at this early stage, we continue to be focused on making year-on-year progress. For the medium to long-term, our Polymer & Parts strategy keeps us well placed to deliver our growth opportunities."

 

Enquiries:

Victrex plc:

Andrew Hanson, Director of Investor Relations & Corporate Communications +44 (0) 7809 595831

Richard Armitage, Group Finance Director +44 (0) 1253 897700

Jakob Sigurdsson, Chief Executive +44 (0) 1253 897700

 

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of Automotive, Aerospace, Energy, Electronics and Medical. Every day, millions of people rely on products or applications which contain our materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 40 years' experience, we are moving beyond the polymer into semi-finished and finished products which shape future performance for our customers and our markets, and drive value for our shareholders. Find out more at www.victrexplc.com

 

Analyst and investor call:

A conference call for analysts and investors will be held this morning at 08.30am GMT. Dial in details +44 (0) 3333 000804 PIN: 94528843#

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTTAMLTMTMMBAM
Date   Source Headline
28th Feb 20239:35 amRNSTotal Voting Rights
17th Feb 202310:06 amRNSDirector/PDMR Shareholding
14th Feb 202312:20 pmRNSDirector/PDMR Shareholding
10th Feb 20232:12 pmRNSDirector/PDMR Shareholding
10th Feb 202312:29 pmRNSResult of AGM
10th Feb 20237:00 amRNSAGM & Q1 Interim Management Statement
31st Jan 202310:43 amRNSTotal Voting Rights
17th Jan 20232:12 pmRNSDirector/PDMR Shareholding
12th Jan 20232:28 pmRNSCorrection - AGM Resolution Proposal
6th Jan 20232:58 pmRNSAnnual Report and Accounts
30th Dec 20229:00 amRNSTotal Voting Rights
22nd Dec 202211:30 amRNSDirector/PDMR Shareholding
19th Dec 202212:04 pmRNSDirector/PDMR Shareholding
19th Dec 202210:56 amRNSDirector/PDMR Shareholding
13th Dec 202211:16 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSVictrex plc – Preliminary Results 2022
1st Dec 202211:49 amRNSBlock listing Interim Review
30th Nov 20229:27 amRNSTotal Voting Rights
29th Nov 20224:05 pmRNSHolding(s) in Company
17th Nov 20222:50 pmRNSDirector/PDMR Shareholding
17th Nov 20221:35 pmRNSAdditional Listing
31st Oct 202212:55 pmRNSTotal Voting Rights
18th Oct 202212:26 pmRNSDirector/PDMR Shareholding
30th Sep 202211:03 amRNSTotal Voting Rights
28th Sep 20229:44 amRNSHolding(s) in Company
20th Sep 20224:05 pmRNSDirector/PDMR Shareholding
31st Aug 20229:00 amRNSTotal Voting Rights
17th Aug 20222:31 pmRNSDirector/PDMR Shareholding
29th Jul 202210:01 amRNSTotal Voting Rights
19th Jul 20222:41 pmRNSDirector/PDMR Shareholding
7th Jul 20227:00 amRNSVictrex Q3 Interim Management Statement
30th Jun 202210:28 amRNSTotal Voting Rights
21st Jun 202212:41 pmRNSDirector/PDMR Shareholding
7th Jun 202211:45 amRNSBlock listing Interim Review
31st May 20229:59 amRNSTotal Voting Rights
27th May 20229:40 amRNSHolding(s) in Company
17th May 20223:58 pmRNSHolding(s) in Company
17th May 202212:19 pmRNSDirector/PDMR Shareholding
13th May 202211:02 amRNSDirector/PDMR Shareholding
9th May 20227:00 amRNSVictrex plc – Interim Results 2022
29th Apr 20221:16 pmRNSTotal Voting Rights
21st Apr 20222:50 pmRNSHolding(s) in Company
20th Apr 202212:20 pmRNSDirector/PDMR Shareholding
5th Apr 20227:00 amRNSDirectorate Change
31st Mar 202210:39 amRNSTotal Voting Rights
22nd Mar 202211:35 amRNSDirector/PDMR Shareholding
18th Mar 202210:09 amRNSHolding(s) in Company
17th Mar 202212:21 pmRNSDirector/PDMR Shareholding
15th Mar 20223:07 pmRNSAdditional Listing
28th Feb 202210:46 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.